News

Published on 11 Feb 2025 on Zacks · via Yahoo Finance

New Strong Buy Stocks for February 11th

Article preview image

Dana Incorporated Price and Consensus Dana Incorporated price-consensus-chart | Dana Incorporated Quote Pacira BioSciences, Inc. PCRX: This non-opioid...

Read the rest of the article
NASDAQ.PCRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Other Stocks to Consider Here are some stocks worth considering from the healthcare space, as our...

Zacks · via Yahoo Finance 17 Feb 2025
HALO Gears Up to Report Q4 Earnings: Here's What You Should Know

Halozyme's fourth-quarter earnings are likely to have gained from higher royalty payments and...

Zacks · via Yahoo Finance 13 Feb 2025
New Strong Buy Stocks for February 11th

Dana Incorporated Price and Consensus Dana Incorporated price-consensus-chart | Dana Incorporated...

Zacks · via Yahoo Finance 11 Feb 2025
Best Value Stocks to Buy for February 11th

The company possesses a Value Score of A. OMV AG PE Ratio (TTM) OMV AG pe-ratio-ttm | OMV AG Quot...

Zacks · via Yahoo Finance 11 Feb 2025
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 17 Jan 2025
Small Business - Cordele Dispatch | Cordele Dispatch

NEW ORLEANS, Jan. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information servic...

Cordele Dispatch 16 Jan 2025
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

Pacira stock gains 11% on better-than-expected preliminary Q4 sales figures. It also shares a...

Zacks · via Yahoo Finance 13 Jan 2025
Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of...

Pacira BioSciences Inc (NASDAQ:PCRX) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

GuruFocus.com · via Yahoo Finance 5 Nov 2024
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira...

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale o...

GuruFocus.com · via Yahoo Finance 20 Jun 2024
Earnings Miss: Pacira BioSciences, Inc. Missed EPS By 17% And Analysts Are Revising Their Forecasts

Investors in Pacira BioSciences, Inc. (NASDAQ:PCRX) had a good week, as its shares rose 9.3% to c...

Simply Wall St. via Yahoo Finance 10 May 2024

Copyright Statfolio @ 2025

Social Accounts